Chargement en cours...

Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.

In the treatment of cardiovascular disease, it could be of therapeutic interest to associate the hypotensive effects due to the inhibition of angiotensin II formation with the diuretic and natriuretic responses induced by the protection of the endogenous atrial natriuretic peptide (ANP). Investigati...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Fournié-Zaluski, M C, Gonzalez, W, Turcaud, S, Pham, I, Roques, B P, Michel, J B
Format: Artigo
Langue:Inglês
Publié: 1994
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC43725/
https://ncbi.nlm.nih.gov/pubmed/8171037
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!